Thaminda Ramanayake

Chief Business Officer CureVac SE

Wednesday 23rd July 2025

Biopharma Business Development & Investors Panel: Secure the Financial Future of mRNA Technology Through Trusting Investor Partnerships

7:55 am

Download the Full Event Guide to see session details.

Tuesday 22nd July 2025

mRNA 2.0: From Hype to Endurance — Building a Durable Future for a Disruptive Modality

9:25 am

Download the Full Event Guide to see session details.